BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1976640)

  • 1. Butyrate blocks the accumulation of CDC2 mRNA in late G1 phase but inhibits both the early and late G1 progression in chemically transformed mouse fibroblasts BP-A31.
    Charollais RH; Buquet C; Mester J
    J Cell Physiol; 1990 Oct; 145(1):46-52. PubMed ID: 1976640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle dependent regulation of cdc2 mRNA in mouse fibroblasts: requirement of protein synthesis and of continued mitogenic stimulation.
    Buquet-Fagot C; Fagot D; Mester J
    J Cell Physiol; 1993 Apr; 155(1):204-9. PubMed ID: 7682222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals.
    Vaziri C; Stice L; Faller DV
    Cell Growth Differ; 1998 Jun; 9(6):465-74. PubMed ID: 9663465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism.
    Buquet-Fagot C; Lallemand F; Charollais RH; Mester J
    J Cell Physiol; 1996 Mar; 166(3):631-6. PubMed ID: 8600167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells.
    Barnard JA; Warwick G
    Cell Growth Differ; 1993 Jun; 4(6):495-501. PubMed ID: 8373733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential role for c-jun in cell cycle progression through late G1 and S.
    Carter R; Cosenza SC; Pena A; Lipson K; Soprano DR; Soprano KJ
    Oncogene; 1991 Feb; 6(2):229-35. PubMed ID: 1900357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimitogenic effects of dexamethasone in chemically transformed mouse fibroblasts.
    Fagot D; Buquet-Fagot C; Mester J
    Endocrinology; 1991 Aug; 129(2):1033-41. PubMed ID: 1906802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells.
    Buckley AR; Leff MA; Buckley DJ; Magnuson NS; de Jong G; Gout PW
    Cell Growth Differ; 1996 Dec; 7(12):1713-21. PubMed ID: 8959340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-dependent mitogenic signal transduction pathway in chemically transformed mouse fibroblasts is similar to but distinct from that initiated by phorbol esters.
    Buchou T; Mĕster J
    J Cell Physiol; 1990 Mar; 142(3):559-65. PubMed ID: 1690214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts.
    Ryseck RP; Hirai SI; Yaniv M; Bravo R
    Nature; 1988 Aug; 334(6182):535-7. PubMed ID: 3136397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle-dependent gene expression in V point-arrested BALB/c-3T3 cells.
    Olson JE; Winston JT; Whitlock JA; Pledger WJ
    J Cell Physiol; 1993 Feb; 154(2):333-42. PubMed ID: 8425914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate inhibits mouse fibroblasts at a control point in the G1 phase.
    Wintersberger E; Mudrak I; Wintersberger U
    J Cell Biochem; 1983; 21(3):239-47. PubMed ID: 6195168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resumption of cell cycle in BALB/c-3T3 fibroblasts arrested by polyamine depletion: relation with "competence" gene expression.
    Charollais RH; Mester J
    J Cell Physiol; 1988 Dec; 137(3):559-64. PubMed ID: 3142887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
    Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
    J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of c-Jun expression during late G1/S in normal human cells is lost in human tumor cells.
    Carter R; Yumet G; Peña A; Soprano DR; Soprano KJ
    Oncogene; 1994 Sep; 9(9):2675-82. PubMed ID: 8058331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosis.
    Janson W; Brandner G; Siegel J
    Oncogene; 1997 Sep; 15(12):1395-406. PubMed ID: 9333015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG; Moses HL
    J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.